ReviewCurrent pharmaceutical biotechnology2025
Recent Nanosolutions Based on Green Propolis Presenting Useful Medical Applications.
Review in Current pharmaceutical biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanotechnology has the potential to offer elegant solutions to problems experienced in the medical field, such as poor drug delivery efficiency and microbial resistance. In this sense, it is interesting to associate nanomaterials with substances that also offer desirable properties to favor human health. Green propolis is an example of a material that contains some of these useful substances. The phenolic acids present in this type of propolis have already been proven to present, for example, antimicrobial, immunostimulant, and antioxidant activities. In this minireview, recent nano solutions based on green propolis, presented through manuscripts recently published, receive attention due to their useful properties in the medical field. Limitations to the clinical use of nanomaterials and the future prospects are also addressed.
Indexed as
Identifiers
38808711What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.